Sedative
Sedation in intensive care and surgical settings
Key Facts
About Dawah Pharmaceuticals
Dawah Pharmaceuticals is a commercial-stage generic drug company employing a capital-light, partnership-driven model to bring essential medicines to market. Its strategy centers on identifying and filling supply gaps for sterile injectable and ophthalmic products by collaborating with top-tier international CMOs, primarily for U.S. market entry. Backed by leadership with decades of healthcare experience, the company is building a diverse pipeline targeting therapeutic areas like critical care, oncology, and CNS disorders, with several product launches projected from 2026 onward. Dawah's approach combines U.S. regulatory expertise with cost-effective global manufacturing to improve drug access and affordability.
View full company profile